China Shineway Pharmaceutical Group Limited

Shineway was selected into the pilot list of Yunnan Province’s TCM formula granules research

Shineway TCM formula Granule production capacity tripled to 2 billion bags

Shineway expects earnings for the first half of 2018 to increase by 40%

Shineway’s TCM Formula Granules added another Class III hospital

Shineway’s OTC products made their way into 780 pharmacy chains

An international medical journal published results of phase II clinical trial of Shineway’s Sai Luo Tong, revealing that it may be safe and effective for treating mild to moderate vascular dementia